Eventide Asset Management, LLC Bolt Biotherapeutics, Inc. Transaction History

Eventide Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.41 - $2.91 $1.21 Million - $2.5 Million	-859,826 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.74 - $4.82 $1.62 Million - $2.84 Million	-589,668 Reduced 40.68%	859,826 $2.36 Million
Q4 2021 Feb 14, 2022	BUY	$4.19 - $13.97 $3.84 Million - $12.8 Million	915,494 Added 171.44%	1,449,494 $7.1 Million
Q2 2021 Aug 16, 2021	BUY	$15.4 - $31.46 $3.25 Million - $6.64 Million	211,056 Added 65.35%	534,000 $8.26 Million
Q1 2021 May 14, 2021	BUY	$25.86 - $39.93 $8.35 Million - $12.9 Million	322,944 New	322,944 $10.6 Million

19.1M

Ticker BOLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,641,500
Market Cap $21.8M
Description
Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-e...

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Eventide Asset Management, LLC with notifications on news.